Telehealth platform for at-home opioid use disorder treatment
Ophelia delivers clinical opioid use disorder (OUD) treatment via telehealth, operating a healthcare tech stack (Firebase + GCP + BigQuery + dbt) paired with Salesforce and Customer.io for patient lifecycle management. The hiring mix—healthcare (5), sales (5), engineering (2)—reflects a clinical-stage business scaling access and referral networks rather than pure product velocity; active projects span outreach, B2B partnerships, and CRM strategy, while pain points cluster around geographic expansion and referral-to-conversion flow.
Ophelia is a telehealth provider delivering evidence-based medication-assisted opioid use disorder treatment in home settings across the United States. Founded in 2020 and headquartered in New York, the company operates a dual-sided model: clinical operations (diagnosis, treatment, medication delivery, monitoring) and referral partnerships with community health systems and primary care networks. The technology stack supports patient onboarding, engagement, and prescriber coordination via a proprietary EMR, with recent projects focused on expanding state coverage, integrating into existing telehealth workflows, and improving retention through automated patient journeys.
Ophelia runs on Firebase and GCP for backend infrastructure, BigQuery for analytics, dbt and Lightdash for data modeling and visualization, Salesforce for referral and provider CRM, and Customer.io for patient engagement campaigns.
Ophelia is headquartered in New York, New York and currently hiring in the United States only.
Other companies in the same industry, closest in size